These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16186601)

  • 1. Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice.
    Hanniman EA; Lambert G; McCarthy TC; Sinal CJ
    J Lipid Res; 2005 Dec; 46(12):2595-604. PubMed ID: 16186601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiatherosclerotic effect of farnesoid X receptor.
    Mencarelli A; Renga B; Distrutti E; Fiorucci S
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H272-81. PubMed ID: 19028791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of FXR in foam-cell formation and atherosclerosis development.
    Guo GL; Santamarina-Fojo S; Akiyama TE; Amar MJ; Paigen BJ; Brewer B; Gonzalez FJ
    Biochim Biophys Acta; 2006 Dec; 1761(12):1401-9. PubMed ID: 17110163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.
    Kong B; Luyendyk JP; Tawfik O; Guo GL
    J Pharmacol Exp Ther; 2009 Jan; 328(1):116-22. PubMed ID: 18948497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice.
    Lee Y; Kim BR; Kang GH; Lee GJ; Park YJ; Kim H; Jang HC; Choi SH
    Endocrinol Metab (Seoul); 2021 Dec; 36(6):1243-1253. PubMed ID: 34986301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
    Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
    Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
    Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
    Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ApoE is a major determinant of hepatic bile acid homeostasis in mice.
    von Hardenberg S; Gnewuch C; Schmitz G; Borlak J
    J Nutr Biochem; 2018 Feb; 52():82-91. PubMed ID: 29175670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice.
    Tsukamoto K; Tangirala R; Chun SH; Puré E; Rader DJ
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2162-70. PubMed ID: 10479659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile.
    Grimsditch DC; Penfold S; Latcham J; Vidgeon-Hart M; Groot PH; Benson GM
    Atherosclerosis; 2000 Aug; 151(2):389-97. PubMed ID: 10924715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation.
    Harja E; Bucciarelli LG; Lu Y; Stern DM; Zou YS; Schmidt AM; Yan SF
    Circ Res; 2004 Feb; 94(3):333-9. PubMed ID: 14670837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.
    Kast HR; Nguyen CM; Sinal CJ; Jones SA; Laffitte BA; Reue K; Gonzalez FJ; Willson TM; Edwards PA
    Mol Endocrinol; 2001 Oct; 15(10):1720-8. PubMed ID: 11579204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Farnesoid-X-receptor blockade reduces myocardial reperfusion injury in cholesterol-fed apolipoprotein E knockout mice].
    Tong H; Shan PR; Zhao YC; Yuan AC; He Q; Yao TB; Ying XY; Pu J; He B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):642-6. PubMed ID: 24225234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response.
    Wang YD; Chen WD; Wang M; Yu D; Forman BM; Huang W
    Hepatology; 2008 Nov; 48(5):1632-43. PubMed ID: 18972444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
    Tangirala RK; Praticó D; FitzGerald GA; Chun S; Tsukamoto K; Maugeais C; Usher DC; Puré E; Rader DJ
    J Biol Chem; 2001 Jan; 276(1):261-6. PubMed ID: 11024044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice.
    Boisvert WA; Curtiss LK
    J Lipid Res; 1999 May; 40(5):806-13. PubMed ID: 10224149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis.
    Lambert G; Amar MJ; Guo G; Brewer HB; Gonzalez FJ; Sinal CJ
    J Biol Chem; 2003 Jan; 278(4):2563-70. PubMed ID: 12421815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.
    Duez H; Chao YS; Hernandez M; Torpier G; Poulain P; Mundt S; Mallat Z; Teissier E; Burton CA; Tedgui A; Fruchart JC; Fiévet C; Wright SD; Staels B
    J Biol Chem; 2002 Dec; 277(50):48051-7. PubMed ID: 12377786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.